Best VPN for Pharmaceuticals

FDA Part 11 puts validation and audit trails on your record systems, not on a VPN. Here is what the rules ask about access, and what a VPN can support.

A traveler working on a laptop at an airport window at dawn

Question 1 of 2

What is behind the search for a VPN for your business?

15,351 VPN picks made through VPN.com in the last 30 days

What the rules ask of you

What Part 11 and Annex 11 ask about access to regulated systems

What does Part 11 ask of a regulated system?

21 CFR 11.10 lists controls for closed systems, including validation, limiting system access to authorised individuals, secure time-stamped audit trails, and authority checks. It does not mention networks or VPNs.

  1. The controls sit on the record system.Validation (11.10(a)) and the audit trail (11.10(e)) belong to the system that holds the regulated records. A VPN is not that system.
  2. Open systems get extra measures.11.30 asks for controls that keep records authentic and intact, and confidential as appropriate, from creation to receipt, with measures such as document encryption. A closed system is one where the people responsible for the records control access (11.3(b)). Which you have is a question for your quality team.
  3. FDA reads the scope narrowly.FDA’s 2003 guidance on Part 11 is non-binding. It says validation and audit-trail decisions should rest on a documented risk assessment, and that requirements in other FDA rules still apply.

General information, not regulatory advice. A VPN alone does not make a company Part 11 compliant, and no VPN is "validated" for you. Validation is your responsibility.

What does the EU ask about access?

Clause 12 of Annex 11 of the EU GMP guidelines says physical or logical controls should restrict access to a computerised system to authorised persons, and that the extent of the controls depends on how critical the system is.

  1. Records of who has access.Clause 12.3 says creating, changing and cancelling access authorisations should be recorded. That is a function of the system and your procedures.
  2. Third parties that maintain systems.Where a supplier maintains a system, for example via remote access, the guideline says formal agreements must state the supplier’s responsibilities.

A VPN can be one logical control on access, alongside the system’s own logins.

By plan

Which plans include the controls

Read from each vendor’s own pages on 8 October 2026; NordLayer was read again on 2 November 2026. These are the vendors’ statements and list prices, not our verdict. We did not check any vendor against Part 11 or Annex 11.

What you are comparingControls the company can switch on, as the vendor saysPrice per user per month, as the vendor lists it
NordLayer CoreSays Core and above can add a dedicated-IP server and IP allow-listing; Lite cannot. Lists SSO and MFA.Lists $11 on yearly billing, 5-user minimum (Lite $8, Premium $14). A dedicated-IP server is +$40 a month.
Proton VPN ProfessionalSays Professional includes dedicated IPs in 20+ countries and SSO. Essentials enforces 2FA.Lists from $9.99, 2-user minimum. The price shown appears to assume a multi-year term.
Cloudflare Zero TrustSays dedicated egress IPs are an Enterprise add-on. Lists SAML SSO and an option to enforce MFA.Lists Free for under 50 users, $7 pay-as-you-go, Enterprise by quote.
GoodAccessSays every plan has a static IP for each gateway. SSO is on Premium and Enterprise only.Lists Essential $7 and Premium $11 on yearly billing, 5-user minimum.

Our verdict

Ask what it claims about Part 11 before regulated work crosses it

Our take: NordLayer is our pick to start with. It lists SSO and MFA and says Core and above can add a dedicated-IP server. We found no Part 11 or validation claim from it, and validation of your own system stays with you.

  • SSO and MFA listed, with one admin console to add and remove people.
  • A dedicated-IP server and IP allow-listing on Core and above, as the vendor says.
  • We found no Part 11 claim from the vendor. Validation is yours.
  • Core lists $11 per user a month on yearly billing, with a 5-user minimum.
NordLayer
  • G2 4.3/5Reviews: 126 · As of October 2026
  • Gartner Peer Insights 4.6/5Ratings: 104 · As of October 2026
  • Easy team rollout
  • Reliable connections
  • Every device encrypted

Why NordLayer is where we would start:

  • Lists SSO and MFA
  • Dedicated IP and IP allow-listing on Core and above
  • One admin console to add and remove people

What NordLayer lists:

  • Lite $8, Core $11, Premium $14 per user a month
  • Yearly billing, 5-user minimum
  • A dedicated-IP server is +$40 a month

Before you commit:

  • Whether it claims anything about Part 11 or GxP
  • Your own system validation and audit trail

The full guide

The detail behind our pick

Bottom line 21 CFR Part 11 does not mention a VPN. It puts validation, access limits and audit trails on the system that holds the electronic records, and the EU’s Annex 11 asks for controls that restrict access to authorised persons. A VPN alone does not make a pharmaceutical company compliant. A business plan can add MFA, single sign-on and a fixed IP in front of those systems.

What this page is for

This page is for the IT, quality or security lead at a pharmaceutical, biotech or contract research company choosing a VPN for staff and partners who reach lab, quality or document systems from outside. It sits under our best VPN for business guide, which explains how a business VPN differs from a personal one. For larger organisations see the enterprise VPN guide. Other regulated fields have different rules; see best VPN for healthcare and best VPN for law firms.

We do not run our own security tests. Every vendor-specific line below is what the vendor says on its own pages, with the date we read it. The regulations are linked under Resources. This is general information, not regulatory advice.

Does FDA Part 11 require a VPN?

No. Part 11 sets controls for electronic records and signatures, and the text of 11.10 does not mention a VPN or a network. The controls it lists, such as validation, access limits and audit trails, apply to the record system. A VPN can support the access side by controlling who reaches the system from outside, but a VPN alone does not make a company Part 11 compliant, and Part 11 does not certify products.

Do I need a business plan or will a small plan do?

It depends less on headcount than on what the VPN sits in front of. A start-up of 3 to 10 people whose regulated records live in a validated system with its own logins and audit trail may need only a small-team plan, because the Part 11 controls are in that system. A multi-device consumer plan has no admin console to add or remove a person and no way to enforce MFA on the VPN sign-in.

TopicWhat the sources say
ValidationA duty on the regulated company’s own system (11.10(a)); the FDA guidance says to base decisions on a documented risk assessment
Limiting access11.10(d) and (g); Annex 11 clause 12.1. A VPN with SSO and MFA can be one layer
Audit trail11.10(e). Belongs to the record system, not the VPN
Records of access changesAnnex 11 clause 12.3. A matter for the system and your procedures
Third-party maintainersAnnex 11 clause 3: written agreements stating responsibilities

Which business plans include the controls

The controls a company can switch on are multi-factor sign-in (MFA, a second proof beyond a password), single sign-on (SSO, so access follows your staff accounts) and dedicated IP or allow-listing (so a system accepts connections only from a fixed address). Each vendor below says what its plans include, read on 8 October 2026.

ProviderDedicated IP or static IPSSOPrice shown per user per month
NordLayerCore and aboveListed$11 (Core), yearly billing
Proton VPN for BusinessProfessionalProfessionalFrom $9.99, appears to assume a multi-year term
Cloudflare Zero TrustEnterprise add-onListedFree under 50 users; $7 pay-as-you-go; Enterprise by quote
GoodAccessEvery planPremium and Enterprise$11 (Premium), yearly billing

Cloudflare and GoodAccess have no review page on VPN.com, so they are not linked internally. NordLayer has no review page either, so NordLayer links to its own site through our partner link. We earn a commission if you buy NordLayer through it; that does not change what its pages say. We did not find, and do not claim, any provider document that says its VPN is Part 11 compliant or validated.

What to ask a VPN company before regulated work goes through it

  1. Which security reports or certifications do you hold, and can I see them? Ask for the report, not just the badge, and check its date.
  2. Do you claim anything about Part 11, GxP or validation? If a vendor says yes, ask for the document. Validation of your own system is still yours.
  3. Is there a written agreement, and who signs it? Annex 11 expects written agreements with third parties that maintain systems.
  4. What does the vendor log, and for how long? Connection logs may matter for your own access records; the audit trail of the regulated record stays in the record system.

Final Verdict

If this is your situationStart with
Records live in a validated system that has its own logins and audit trailA small business plan as a connection layer, then focus on the system’s controls
You want MFA, SSO and a fixed IP in front of lab or quality systemsNordLayer Core or Proton VPN Professional, as each vendor says. Compare the term you must commit to
Your quality team asks for evidenceThe vendor’s security reports and a written agreement, not the badge
You want a static IP on every planGoodAccess, as the vendor says

The VPN is one control. Your validated systems, procedures and quality team decide the rest.

References

  1. ECFR. n.d. 21 CFR Part 11: Electronic Records; Electronic Signatures (eCFR). https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-11.
  2. FDA. n.d. Part 11 Electronic Records Electronic Signatures Scope and Application. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application.
  3. Europa. n.d. European Commission: EU GMP Annex 11, Computerised Systems. https://health.ec.europa.eu/system/files/2016-11/annex11_01-2011_en_0.pdf.
  4. Nordlayer. n.d. NordLayer pricing. https://nordlayer.com/pricing/.

Frequently Asked Questions

Does FDA 21 CFR Part 11 require a VPN?

No. 21 CFR 11.10 lists controls for electronic records systems, including validation, access limits and audit trails, and does not mention networks or VPNs. A VPN can support access control.

Can a VPN be validated or certified as Part 11 compliant?

We found no such certification. Part 11 puts validation (11.10(a)) on the regulated company’s own system, and FDA’s 2003 guidance says to base validation decisions on a documented risk assessment. Treat a vendor’s “Part 11 compliant” claim as a statement to verify with documents.

What does EU Annex 11 say about access to computerised systems?

Clause 12.1 says physical or logical controls should restrict access to authorised persons, and 12.2 says the extent depends on how critical the system is. Clause 12.3 says access authorisations should be recorded. A VPN alone does not satisfy Annex 11, but it can be one logical control.

Is a VPN enough to protect clinical or manufacturing data?

No. A VPN protects the connection, not the record system, the user accounts or the procedures. Part 11 and Annex 11 ask for validation, access limits and audit trails on the system.

Does a VPN create the audit trail Part 11 requires?

No. 11.10(e) asks for a secure, computer-generated, time-stamped audit trail of operator actions on the electronic record, which the record system produces. A VPN’s connection log is a different thing, though it may help your own access records. A VPN alone does not provide a Part 11 audit trail.

What does a business VPN cost a small pharma company per user?

At the vendors we read on 8 October 2026, list prices ran from about $7 to $11 per user per month on the plans in the table, and Cloudflare Zero Trust Enterprise is by quote. NordLayer lists $11 for Core on yearly billing, and a dedicated-IP server is an extra monthly fee.

Can a small biotech use a consumer VPN instead of a business plan?

Possibly for connection privacy, if the regulated records sit in a validated system with its own logins and audit trail. A consumer plan has no admin console to add or remove people and no way to enforce MFA on the VPN sign-in.

Why would a pharma company want a dedicated IP address on its VPN?

A dedicated IP gives the company one fixed address, so a lab, quality or hosting system can be set to accept connections only from it. NordLayer says Core and above can add a dedicated-IP server and IP allow-listing. Whether a system supports that is a question for its own vendor.

What should a pharma company ask a VPN company before regulated work goes through it?

Ask which security reports it holds and whether you can see them, whether it claims anything about Part 11, GxP or validation, whether a written agreement exists and who signs it, which controls your plan includes, and what it logs.